Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julian Oliver Kim"'
Autor:
Bindu Venugopal, Shaheer Shahhat, James Beck, Nikesh Hanumanthappa, Aldrich D. Ong, Arbind Dubey, Rashmi Koul, Bashir Bashir, Amitava Chowdhury, Gokulan Sivananthan, Julian Oliver Kim
Publikováno v:
Current Oncology, Vol 30, Iss 6, Pp 5560-5573 (2023)
Background: Radiation therapy (RT) is an established palliative treatment for bone metastases; however, little is known about post-radiation survival and factors which impact it. The aim of this study was to assess a population-based sample of metast
Externí odkaz:
https://doaj.org/article/a62a906156704010ac0a490be012fe82
Autor:
Biniam Kidane, Gefei Qing, Shantanu Banerji, Lawrence Tan, Sadeesh Srinathan, Michael Domaratzki, Robert Balshaw, David E. Dawe, Leigh C. Murphy, Michel Aliani, Connel Trevena, Julian Oliver Kim, Gordon Buduhan
Objectives: Metabolomics is a potential means for biofluid-based lung cancer detection. We conducted a non-targeted, data-driven, assessment of plasma from early-stage non-small cell lung cancer (ES-NSCLC) cases versus cancer-free controls (CFC) to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10d37e437d318b4712ada84f18a61982
https://doi.org/10.21203/rs.3.rs-944686/v1
https://doi.org/10.21203/rs.3.rs-944686/v1
Autor:
Julian Oliver Kim, Debjani Grenier, Sandhya Pruthi, Jason P. Sinnwell, Andrew Cooke, W. Edward Highsmith, Celine M. Vachon, Fergus J. Couch, Benjamin A Goldenberg, Christina Kim, Amy C. Degnim, Daniel J. Schaid
Publikováno v:
Journal of Clinical Oncology. 37:1501-1501
1501 Background: Despite BC risk reduction of 50-65% by preventive endocrine therapy (ET), very few at-risk women choose to take them. A woman’s perceived BC risk correlates with uptake of ET. A PRS comprised of 77 BC genetic susceptibility loci (S